Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 20,000 shares at $36.17 ($723K) on 2020-09-08, disclosed to the SEC on 2020-09-09.
Open-market sale of $723k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |